TNKS and neoplasm: Regarding antitumor activity of tankyrase inhibitors, especially its effect on the (tumor) vasculature deserves careful consideration as any systemic application of tankyrase inhibitors would come directly in contact with and pass the endothelial cells (EC) lining the vasculature.